These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 26239453)

  • 1. Can Novel Treatment of Age-Related Macular Degeneration Be Developed by Better Understanding of Sorsby's Fundus Dystrophy.
    Gourier HC; Chong NV
    J Clin Med; 2015 May; 4(5):874-83. PubMed ID: 26239453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accumulation of tissue inhibitor of metalloproteinases-3 in human eyes with Sorsby's fundus dystrophy or retinitis pigmentosa.
    Fariss RN; Apte SS; Luthert PJ; Bird AC; Milam AH
    Br J Ophthalmol; 1998 Nov; 82(11):1329-34. PubMed ID: 9924344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TIMP-3, collagen, and elastin immunohistochemistry and histopathology of Sorsby's fundus dystrophy.
    Chong NH; Alexander RA; Gin T; Bird AC; Luthert PJ
    Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):898-902. PubMed ID: 10711711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sorsby's fundus dystrophy is genetically linked to chromosome 22q13-qter.
    Weber BH; Vogt G; Wolz W; Ives EJ; Ewing CC
    Nat Genet; 1994 Jun; 7(2):158-61. PubMed ID: 7920634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the collagen VI assemblies associated with Sorsby's fundus dystrophy.
    Knupp C; Chong NH; Munro PM; Luthert PJ; Squire JM
    J Struct Biol; 2002; 137(1-2):31-40. PubMed ID: 12064931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sorsby's fundus dystrophy: what does TIMP3 tell us about general mechanisms underlying macular degeneration?
    Tymms MJ
    Clin Exp Optom; 1999; 82(4):124-129. PubMed ID: 12482286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sorsby's fundus dystrophy. A clinical study.
    Polkinghorne PJ; Capon MR; Berninger T; Lyness AL; Sehmi K; Bird AC
    Ophthalmology; 1989 Dec; 96(12):1763-8. PubMed ID: 2622621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Sorsby's fundus dystrophy mutations in human retinal pigment epithelial cells reduces matrix metalloproteinase inhibition and may promote angiogenesis.
    Qi JH; Ebrahem Q; Yeow K; Edwards DR; Fox PL; Anand-Apte B
    J Biol Chem; 2002 Apr; 277(16):13394-400. PubMed ID: 11821400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TIMP3 mutation in Sorsby's fundus dystrophy: molecular insights.
    Li Z; Clarke MP; Barker MD; McKie N
    Expert Rev Mol Med; 2005 Oct; 7(24):1-15. PubMed ID: 16259644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features of a novel TIMP-3 mutation causing Sorsby's fundus dystrophy: implications for disease mechanism.
    Clarke M; Mitchell KW; Goodship J; McDonnell S; Barker MD; Griffiths ID; McKie N
    Br J Ophthalmol; 2001 Dec; 85(12):1429-31. PubMed ID: 11734514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sorsby's fundus dystrophy. A light and electron microscopic study.
    Capon MR; Marshall J; Krafft JI; Alexander RA; Hiscott PS; Bird AC
    Ophthalmology; 1989 Dec; 96(12):1769-77. PubMed ID: 2482957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histologic and morphometric analysis of the choroid, Bruch's membrane, and retinal pigment epithelium in postmortem eyes with age-related macular degeneration and histologic examination of surgically excised choroidal neovascular membranes.
    Spraul CW; Lang GE; Grossniklaus HE; Lang GK
    Surv Ophthalmol; 1999 Oct; 44 Suppl 1():S10-32. PubMed ID: 10548114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antiangiogenic therapy in Sorsby's fundus dystrophy without a mutation in the TIMP-3 gene].
    Copete-Piqueras S; Cava-Valenciano C; Flores-Moreno I; Moreno-Valladares A; Bautista Ruescas V
    Arch Soc Esp Oftalmol; 2013 Jun; 88(6):240-3. PubMed ID: 23726310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dynamic nature of Bruch's membrane.
    Booij JC; Baas DC; Beisekeeva J; Gorgels TG; Bergen AA
    Prog Retin Eye Res; 2010 Jan; 29(1):1-18. PubMed ID: 19747980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sorsby's fundus dystrophy in a family with a Ser-181-CVS mutation in the TIMP-3 gene: poor outcome after laser photocoagulation.
    Sieving PA; Boskovich S; Bingham E; Pawar H
    Trans Am Ophthalmol Soc; 1996; 94():275-94; discussion 295-7. PubMed ID: 8981701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sorsby's fundus dystrophy mutations impair turnover of TIMP-3 by retinal pigment epithelial cells.
    Langton KP; McKie N; Smith BM; Brown NJ; Barker MD
    Hum Mol Genet; 2005 Dec; 14(23):3579-86. PubMed ID: 16223891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sorsby's fundus dystrophy tissue inhibitor of metalloproteinases-3 (TIMP-3) mutants have unimpaired matrix metalloproteinase inhibitory activities, but affect cell adhesion to the extracellular matrix.
    Yeow KM; Kishnani NS; Hutton M; Hawkes SP; Murphy G; Edwards DR
    Matrix Biol; 2002 Jan; 21(1):75-88. PubMed ID: 11827795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sorsby fundus dystrophy - A review of pathology and disease mechanisms.
    Christensen DRG; Brown FE; Cree AJ; Ratnayaka JA; Lotery AJ
    Exp Eye Res; 2017 Dec; 165():35-46. PubMed ID: 28847738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue inhibitor of metalloproteinase-3 differentially binds to components of Bruch's membrane.
    Majid MA; Smith VA; Matthews FJ; Newby AC; Dick AD
    Br J Ophthalmol; 2006 Oct; 90(10):1310-5. PubMed ID: 16837541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue inhibitor of metalloproteinases-3 is a component of Bruch's membrane of the eye.
    Fariss RN; Apte SS; Olsen BR; Iwata K; Milam AH
    Am J Pathol; 1997 Jan; 150(1):323-8. PubMed ID: 9006347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.